A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer.
Kim JH, Kim HS, Choi DR, Jang G, Kwon JH, Kim HY, Jung JY, Kim HJ, Song HH, Shin YH, Jung SY, Kim BC, Zang DY.
Kim JH, et al. Among authors: jung jy, jung sy.
Oncol Lett. 2011 Nov;2(6):1253-1256. doi: 10.3892/ol.2011.367. Epub 2011 Jul 27.
Oncol Lett. 2011.
PMID: 22848297
Free PMC article.